Intratumoral CXCL12 Gradients Contextualize Tumor Cell Invasion, Migration and Immune Suppression in Breast Cancer
Anastasiadou, D. P.; Couturier, N.; Goel, S.; Argyris, D. G.; Vodopyanov, S.; Rivera-Sanchez, L.; Gonzalez, E.; Kreger, J.; Griffen, A.; Kazakov, A.; Burt, J.; Recoder, N.; Duran, C. L.; Harney, A. S.; Quesnel, A.; Filippou, P. S.; Lenis, V. P.; Shukla, S.; Entenberg, D.; Zintiridou, A.; Chen, X.; Eddy, R. J.; Oktay, M. H.; Condeelis, J. S.; Karagiannis, N. S.; Briceno, A.; Guzik, H.; Alon, R.; DesMarais, V.; Ioannou, G.; Gnjatic, S.; Raynolds, D. M.; Macedo, R.; Reshef, R.; Gil-Henn, H.; MacLean, A. L.; Roussos Torres, E.; LaFave, L. M.; Lauvau, G.; Karagiannis, G. S.
Show abstract
Although the CXCL12/CXCR4 pathway has been prior investigated for its prometastatic and immuno- suppressive roles in the tumor microenvironment, evidence on the spatiotemporal regulation of these hallmarks has been lacking. Here, we demonstrate that CXCL12 forms a gradient specifically around cancer cell intravasation doorways, also known as Tumor Microenvironment of Metastasis (TMEM) doorways, thus facilitating the chemotactic translocation of prometastatic tumor cells expressing CXCR4 toward the perivascular TMEM doorways for subsequent entry into peripheral circulation. Fur- thermore, we demonstrate that the CXCL12-rich micro-environment around TMEM doorways may cre- ate immunosuppressive niches, whereby CD8+ T cells, despite being attracted to these regions, often exhibit reduced effector functions, limiting their efficacy. While the CXCL12/CXCR4 pathway can mini- mally influence the overall composition of immune cell populations, it biases the distribution of CD8+ T cells away from TMEM doorways, justifying its prior-established role as immunosuppressive factor for CD8+ T cells. Our research suggests that the complex interactions between CXCL12 and the various tumor and immune cell types contributes not only to the completion of the initial steps of the metastatic cascade, but also offers an immunological "sanctuary" to prometastatic tumor cells homed around TMEM doorways. Overall, our study enhances our current understanding on the mechanisms, via which CXCL12 orchestrates tumor cell behavior and immune dynamics, potentially guiding future thera- peutic strategies to combat breast cancer metastasis and improve anti-tumor immunity.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells 98%
- A SNAI2-PEAK1 stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting a cytokine expression profile that converges on PI3K/Akt signaling 95%
- Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma 94%
Similar papers in this journal
- Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma 96%
- Microenvironmental correlates of immune checkpoint inhibitor response in human melanoma brain metastases revealed by T cell receptor and single-cell RNA sequencing 96%
- Lung cancer-intrinsic SOX2 expression mediates resistance to checkpoint blockade therapy by inducing Treg-dependent CD8+ T cell exclusion 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.